SCHEMBL23313264

SCHEMBL23313264

Cn1ccc(-c2cn([C@@H]3O[C@H](COc4ccc5ccc(C6CCC6)nc5c4)[C@@H](O)[C@@H]3F)c3ncnc(N)c23)n1

nearest known ligand 0.79

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 11/20 0.79
▸ METTL3 Q86U44 11/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23313273 0.90 METTL3 (0.87) PRMT5METTL3
SCHEMBL23313145 0.90 METTL3 (0.78) PRMT5METTL3
SCHEMBL23313037 0.89 METTL3 (0.88) PRMT5METTL3
SCHEMBL23313081 0.88 PRMT5 (1.00) PRMT5METTL3
SCHEMBL23313051 0.87 METTL3 (1.00) PRMT5METTL3
SCHEMBL25015997 0.87 PRMT5 (0.60) PRMT5METTL3
SCHEMBL23313271 0.87 METTL3 (0.91) PRMT5METTL3
SCHEMBL23313941 0.86 PRMT5 (1.00) PRMT5METTL3
SCHEMBL23313267 0.86 PRMT5 (0.74) PRMT5METTL3
SCHEMBL23313286 0.86 METTL3 (0.80) PRMT5METTL3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021079196-A9 METTL3 MODULATORS ACCENT THERAPEUTICS, INC (US) 2022-07-14 — — WO disclosed
WO-2021079196-A2 METTL3 MODULATORS ACCENT THERAPEUTICS, INC (US) 2021-04-29 — — WO disclosed
Send feedback